1. Home
  2. BRTX vs STRR Comparison

BRTX vs STRR Comparison

Compare BRTX & STRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRTX
  • STRR
  • Stock Information
  • Founded
  • BRTX 1997
  • STRR 1985
  • Country
  • BRTX United States
  • STRR United States
  • Employees
  • BRTX N/A
  • STRR N/A
  • Industry
  • BRTX Managed Health Care
  • STRR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • BRTX Health Care
  • STRR Health Care
  • Exchange
  • BRTX Nasdaq
  • STRR Nasdaq
  • Market Cap
  • BRTX 12.6M
  • STRR 6.3M
  • IPO Year
  • BRTX N/A
  • STRR N/A
  • Fundamental
  • Price
  • BRTX $1.67
  • STRR $2.00
  • Analyst Decision
  • BRTX Strong Buy
  • STRR Strong Buy
  • Analyst Count
  • BRTX 1
  • STRR 1
  • Target Price
  • BRTX $18.00
  • STRR $5.00
  • AVG Volume (30 Days)
  • BRTX 256.1K
  • STRR 21.4K
  • Earning Date
  • BRTX 08-12-2025
  • STRR 08-12-2025
  • Dividend Yield
  • BRTX N/A
  • STRR N/A
  • EPS Growth
  • BRTX N/A
  • STRR N/A
  • EPS
  • BRTX N/A
  • STRR N/A
  • Revenue
  • BRTX $391,000.00
  • STRR $57,165,000.00
  • Revenue This Year
  • BRTX $391.52
  • STRR $33.64
  • Revenue Next Year
  • BRTX $3.50
  • STRR $22.87
  • P/E Ratio
  • BRTX N/A
  • STRR N/A
  • Revenue Growth
  • BRTX 161.54
  • STRR 34.33
  • 52 Week Low
  • BRTX $1.21
  • STRR $1.72
  • 52 Week High
  • BRTX $2.55
  • STRR $5.35
  • Technical
  • Relative Strength Index (RSI)
  • BRTX 46.78
  • STRR 45.82
  • Support Level
  • BRTX $1.57
  • STRR $1.95
  • Resistance Level
  • BRTX $1.72
  • STRR $2.02
  • Average True Range (ATR)
  • BRTX 0.13
  • STRR 0.07
  • MACD
  • BRTX -0.01
  • STRR -0.00
  • Stochastic Oscillator
  • BRTX 20.65
  • STRR 36.84

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

About STRR Star Equity Holdings Inc.

Star Equity Holdings Inc is a multi-industry diversified holding company. It operates in two segments: Building Solutions segment, through KBS, EBGL and TT, it services residential and commercial construction projects by manufacturing modular housing units, structural wall panels, permanent wood foundation systems, other engineered wood products, and supply general contractors with building materials; and Investments segment, which holds corporate-owned real estate, currently includes one manufacturing facility and the equipment for another manufacturing facility in Maine that it leases back to KBS and its manufacturing facility in Wisconsin that it leases back to TT. The company derives maximum revenue from Building Solutions Segment.

Share on Social Networks: